Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Elvert

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|April 28, 2017
Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor AgonistsAndreas Evers, Torsten Haack, Martin Lorenz, et al.
Journal of Medicinal Chemistry|June 8, 2018
Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose FormulationsAndreas Evers, Martin Bossart, Stefania Pfeiffer-Marek, et al.
Endocrinology|July 12, 2018
Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic MonkeysRalf Elvert, Martin Bossart, Andreas W Herling, et al.
Diabetes, Obesity & Metabolism|March 21, 2020
Incretin combination therapy for the treatment of non-alcoholic steatohepatitisAimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, et al.
Diabetes, Obesity & Metabolism|June 26, 2018
Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primatesRalf Elvert, Andreas W Herling, Martin Bossart, et al.
Frontiers in Physiology|August 25, 2022
Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargementZeynep E Yesilyurt, Jan Matthes, Edith Hintermann, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2020
The Novel Phosphate and Bile Acid Sequestrant Polymer SAR442357 Delays Disease Progression in a Rat Model of Diabetic NephropathyTamara R Castañeda, María Méndez, Ian Davison, et al.
European Journal of Oral Sciences|July 21, 2012
Does enamelin have pleiotropic effects on organs other than the teeth? Lessons from a phenotyping screen of two enamelin-mutant mouse linesHelmut Fuchs, Sibylle Sabrautzki, Hartwig Seedorf, et al.
Hepatology Communications|July 7, 2020
Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in MiceDieter Schmoll, Nicole Ziegler, Benoit Viollet, et al.
Journal of Biomedical Science|August 3, 2014
Standardized, systemic phenotypic analysis of Slc12a1I299F mutant miceElisabeth Kemter, Birgit Rathkolb, Lore Becker, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|April 28, 2017
Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor AgonistsAndreas Evers, Torsten Haack, Martin Lorenz, et al.
Journal of Medicinal Chemistry|June 8, 2018
Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose FormulationsAndreas Evers, Martin Bossart, Stefania Pfeiffer-Marek, et al.
Endocrinology|July 12, 2018
Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic MonkeysRalf Elvert, Martin Bossart, Andreas W Herling, et al.
Diabetes, Obesity & Metabolism|March 21, 2020
Incretin combination therapy for the treatment of non-alcoholic steatohepatitisAimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, et al.
Diabetes, Obesity & Metabolism|June 26, 2018
Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primatesRalf Elvert, Andreas W Herling, Martin Bossart, et al.
Frontiers in Physiology|August 25, 2022
Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargementZeynep E Yesilyurt, Jan Matthes, Edith Hintermann, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2020
The Novel Phosphate and Bile Acid Sequestrant Polymer SAR442357 Delays Disease Progression in a Rat Model of Diabetic NephropathyTamara R Castañeda, María Méndez, Ian Davison, et al.
European Journal of Oral Sciences|July 21, 2012
Does enamelin have pleiotropic effects on organs other than the teeth? Lessons from a phenotyping screen of two enamelin-mutant mouse linesHelmut Fuchs, Sibylle Sabrautzki, Hartwig Seedorf, et al.
Hepatology Communications|July 7, 2020
Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in MiceDieter Schmoll, Nicole Ziegler, Benoit Viollet, et al.
Journal of Biomedical Science|August 3, 2014
Standardized, systemic phenotypic analysis of Slc12a1I299F mutant miceElisabeth Kemter, Birgit Rathkolb, Lore Becker, et al.
Pageof 3